1. medino.com /
2. Weight Loss /
3. FAQs /

What did the OASIS 4 clinical trial show about the Wegovy pill?

The OASIS 4 clinical trial showed that once-daily oral semaglutide 25mg, used as the Wegovy pill, helped adults with obesity or overweight lose significantly more weight than placebo. Over 64 weeks, people taking oral semaglutide lost an average of 13.6% of their body weight, compared with 2.2% for those taking placebo.

Key points:

• The Wegovy pill showed significant weight loss results in OASIS 4.
• Participants taking oral semaglutide 25mg lost more weight than those taking placebo.
• The trial followed participants over 64 weeks.
• The results support oral semaglutide as a weight management option where licensed and available.

This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.